These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11697748)

  • 1. Effects of morphine withdrawal on catecholaminergic neurons on heart right ventricle; implication of dopamine receptors.
    Milanés MV; Marín MT; Laorden ML
    Can J Physiol Pharmacol; 2001 Oct; 79(10):885-91. PubMed ID: 11697748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement Of alpha(1)- and alpha(2)-adrenoceptors.
    Milanés MV; Laorden ML
    Eur J Pharmacol; 2000 Jun; 397(2-3):311-8. PubMed ID: 10844129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
    Almela P; Victoria Milanés M; Luisa Laorden M
    Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of U-50,488H withdrawal on catecholaminergic neurones of the rat ventricle.
    Milanés MV; Laorden ML
    Br J Pharmacol; 1998 Jul; 124(6):1060-4. PubMed ID: 9720773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart.
    González-Cuello A; Milanés MV; Laorden ML
    Eur J Pharmacol; 2004 Dec; 506(2):119-28. PubMed ID: 15588731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholaminergic activity and 3',5'-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal.
    Milanés MV; Fuente T; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):61-6. PubMed ID: 10651148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat hearts.
    Rabadán JV; Milanés MV; Laorden ML
    J Pharmacol Exp Ther; 1997 Jan; 280(1):32-7. PubMed ID: 8996178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral activation induced by D(2)-like receptor stimulation during opiate withdrawal.
    Druhan JP; Walters CL; Aston-Jones G
    J Pharmacol Exp Ther; 2000 Aug; 294(2):531-8. PubMed ID: 10900229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
    Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P
    J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T; Matsumura T; Ukai M
    Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
    González-Cuello A; Milanés MV; Castells MT; Laorden ML
    Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
    González-Cuello A; Milanés MV; Aviles M; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):17-25. PubMed ID: 15249992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors.
    Flores JA; El Banoua F; Galán-Rodríguez B; Fernandez-Espejo E
    Pain; 2004 Jul; 110(1-2):205-14. PubMed ID: 15275769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats.
    Funada M; Shippenberg TS
    Behav Pharmacol; 1996 Oct; 7(5):448-453. PubMed ID: 11224440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.
    Zhou Q; Kindlundh AM; Hallberg M; Nyberg F
    Peptides; 2004 Nov; 25(11):1951-7. PubMed ID: 15501527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
    Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
    Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-induced antinociception in the formalin test: sensitization and interactions with D1 and D2 dopamine receptors and nitric oxide agents.
    Zarrindast MR; Asgari-Afshar A; Sahebgharani M
    Behav Pharmacol; 2007 May; 18(3):177-84. PubMed ID: 17426481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.